Publikationen von Matthias L. Schroeter

Florek, L.; Tiepolt, S.; Schroeter, M. L.; Berrouschot, J.; Saur, D.; Hesse, S.; Jochimsen, T.; Luthardt, J.; Sattler, B.; Patt, M. et al.; Hoffmann, K.-T.; Villringer, A.; Classen, J.; Gertz, H.-J.; Sabri, O.; Barthel, H.: Dual time-point [¹⁸F]florbetaben PET delivers dual biomarker information in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease 66 (3), S. 1105 - 1116 (2018)

Mueller, K.; Jech, R.; Růžička, F.; Holiga, Š.; Ballarini, T.; Bezdicek, O.; Möller, H. E.; Vymazal, J.; Růžička, E.; Schroeter, M. L. et al.; Urgošík, D.: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease. NeuroImage: Clinical 19, S. 1025 - 1035 (2018)

Tiepolt, S.; Schäfer, A.; Rullmann, M.; Roggenhofer, E.; Netherlands Brain Bank; Gertz, H.-J.; Schroeter, M. L.; Patt, M.; Bazin, P.-L.; Jochimsen, T. H. et al.; Turner, R.; Sabri, O.; Barthel, H.: Quantitative susceptibility mapping of amyloid-β aggregates in Alzheimer’s disease with 7T MR. Journal of Alzheimer's Disease 64 (2), S. 393 - 404 (2018)

Frisch, S.; Thiel, F.; Schroeter, M. L.; Jentzsch, R. T.: Apathy and cognitive deficits in patients with transient global ischemia after cardiac arrest. Cognitive and Behavioral Neurology 30 (4), S. 172 - 175 (2017)

Rodriguez, F. S.; Schroeter, M. L.; Witte, V.; Engel, C.; Löffler, M.; Thiery, J.; Villringer, A.; Luck, T.; Riedel-Heller, S. G.: Could high mental demands at work offset the adverse association between social isolation and cognitive functioning?: Results of the population-based LIFE-adult-study. The American Journal of Geriatric Psychiatry 25 (11), S. 1258 - 1269 (2017)

Beyer, F.; Kharabian, S.; Huntenburg, J. M.; Lampe, L.; Luck, T.; Riedel-Heller, S. G.; Loeffler, M.; Schroeter, M. L.; Stumvoll, M.; Villringer, A. et al.; Witte, V.: Higher body mass index is associated with reduced posterior default mode connectivity in older adults. Human Brain Mapping 38 (7), S. 3502 - 3515 (2017)

Lehmer, C.; Oeckl, P.; Weishaupt, J. H.; Volk, A. E.; Diehl-Schmid, J.; Schroeter, M. L.; Lauer, M.; Kornhuber, J.; Levin, J.; Fassbender, K. et al.; Landwehrmeyer, B.; German Consortium for Frontotemporal Lobar Degeneration; Schludi, M. H.; Arzberger, T.; Kremmer, E.; Flatley, A.; Feederle, R.; Steinacker, P.; Weydt, P.; Ludolph, A. C.; Edbauer, D.: Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. Embo Molecular Medicine 9 (7), S. 859 - 868 (2017)

Polyakova, M.; Schlögl , H.; Sacher, J.; Schmidt-Kassow , M.; Kaiser, J.; Stumvoll, M.; Kratzsch, J.; Schroeter, M. L.: Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations. International Journal of Molecular Sciences 18 (6), 1189 (2017)

Luck, T.; Then, F. S.; Schroeter, M. L.; Witte, V.; Engel, C.; Loeffler, M.; Thiery, J.; Villringer, A.; Riedel-Heller, S. G.: Prevalence of DSM-5 mild neurocognitive disorder in dementia-free older adults: Results of the population-based LIFE-adult-study. The American Journal of Geriatric Psychiatry 25 (4), S. 328 - 339 (2017)

Albrecht, F.; Bisenius, S.; Schaack, R. M.; Neumann, J.; Schroeter, M. L.: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses. npj Parkinson's Disease 3, 12 (2017)

Mueller, K.; Jech, R.; Bonnet, C.; Tintěra, J.; Hanuška, J.; Möller, H. E.; Fassbender, K.; Ludolph, A.; Kassubek, J.; Otto, M. et al.; Růžička, E.; Schroeter, M. L.; The FTLDc Study Group: Disease-specific regions outperform whole-brain approaches in identifying progressive supranuclear palsy: A multicentric MRI study. Frontiers in Neuroscience 11, 100 (2017)

Kharabian, S.; Herzig, S.; Klose, L.; Roggenhofer, E.; Tenckhoff, H.; Kaiser, T.; Thöne-Otto, A.; Wiese, M.; Berg, T.; Schroeter, M. L. et al.; Margulies, D. S.; Villringer, A.: Functional connectivity alterations in patients with chronic hepatitis C virus infection: A multimodal MRI study. Journal of Viral Hepatitis 24 (3), S. 216 - 225 (2017)

Liem, F.; Varoquaux, G.; Kynast, J.; Beyer, F.; Kharabian, S.; Huntenburg, J. M.; Lampe, L.; Rahim, M.; Abraham, A.; Craddock, R. C. et al.; Riedel-Heller, S.; Luck, T.; Loeffler, M.; Schroeter, M. L.; Witte, V.; Villringer, A.; Margulies, D. S.: Predicting brain-age from multimodal imaging data captures cognitive impairment. NeuroImage 148, S. 179 - 188 (2017)

Steinacker, P.; Semler, E.; Anderl-Straub, S.; Diehl-Schmid, J.; Schroeter, M. L.; Uttner, I.; Foerstl, H.; Landwehrmeyer, B.; von Arnim, C. A.F.; Kassubek, J. et al.; Oeckl, P.; Huppertz, H.-J.; Fassbender, K.; Fliessbach, K.; Prudlo, J.; Roßmeier, C.; Kornhuber, J.; Schneider , A.; Volk, A. E.; Lauer, M.; Danek, A.; Ludolph, A. C.; Otto, M.: Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology 88 (10), S. 961 - 969 (2017)

Bisenius, S.; Mueller, K.; Diehl-Schmid, J.; Fassbender, K.; Grimmer, T.; Jessen, F.; Kassubek, J.; Kornhuber, J.; Landwehrmeyer, B.; Ludolph, A. et al.; Schneider, A.; Anderl-Straub, S.; Stuke, K.; Danek, A.; Otto, M.; Schroeter, M. L.; The FTLDc Study Group: Predicting primary progressive aphasias with support vector machine approaches in structural MRI data. NeuroImage: Clinical 14, S. 334 - 343 (2017)

Meyer, S.; Mueller, K.; Stuke, K.; Bisenius, S.; Diehl-Schmid, J.; Jessen, F.; Kassubek, J.; Kornhuber, J.; Ludolph, A. C.; Prudlo, J. et al.; Schneider, A.; Schümberg, K.; Yakushev, I.; Otto, M.; Schroeter, M. L.; The FTLDc Study Group: Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI data. NeuroImage: Clinical 14, S. 656 - 662 (2017)

Schütz, L.; Lobsien, D.; Fritzsch, D.; Tiepolt, S.; Werner, P.; Schroeter, M. L.; Berrouschot, J.; Saur, D.; Hesse, S.; Jochimsen, T. et al.; Rullmann, M.; Sattler, B.; Patt, M.; Gertz, H.-J.; Villringer, A.; Claßen, J.; Hoffmann, K.-T.; Sabri, O.; Barthel, H.: Feasibility and acceptance of simultaneous amyloid PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging 43 (12), S. 2236 - 2243 (2016)

Teipel, S.; Raiser, T.; Riedl, L.; Riederer, I.; Schroeter, M. L.; Bisenius, S.; Schneider, A.; Kornhuber, J.; Fliessbach, K.; Spottke, A. et al.; Grothe, M. J.; Prudlo, J.; Kassubek, J.; Ludolph, A.; Landwehrmeyer, B.; Straub, S.; Otto, M.; Danek, A.; the FTLDc Study Group: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia. Cortex 83, S. 124 - 135 (2016)

Bisenius, S.; Neumann, J.; Schroeter, M. L.: Response to the letter on ‘Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta-analyses’. European Journal of Neurology 23 (8), S. e52 - e53 (2016)

Tiepolt, S.; Hesse, S.; Patt, M.; Luthardt, J.; Schroeter, M. L.; Hoffmann, K.-T.; Weise, D.; Gertz, H.-J.; Sabri, O.; Barthel, H.: Early [¹⁸F]florbetaben and [¹¹C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 43 (9), S. 1700 - 1709 (2016)